Antiphospholipid Syndrome and the Lungs
Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterised by recurrent thromboembolic events (arterial or venous) and/or morbidity in pregnancy (fetal loss, premature birth, or recurrent embryonic losses) in the presence of laboratory evidence of antiphospholipid antibodies (aPL...
Main Authors: | Süreyya Yılmaz, Zülfükar Yılmaz |
---|---|
Format: | Article |
Language: | English |
Published: |
European Medical Journal
2017-03-01
|
Series: | European Medical Journal |
Subjects: | |
Online Access: | https://www.emjreviews.com/rheumatology/article/antiphospholipid-syndrome-and-the-lungs/ |
Similar Items
-
Diffuse alveolar haemorrhage as a rare complication of antiphospholipid syndrome
by: Bhagavata Srinivasan, S.P, et al.
Published: (2022) -
Prevalence and clinical correlates of antiphospholipid antibodies in South Africans with systemic lupus erythematosus
by: Gould, Trevor John
Published: (2008) -
Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy
by: Thomas Fleetwood, et al.
Published: (2018-11-01) -
ANTIPHOSPHOLIPID SYNDROME: DIAGNOSIS AND CLINICAL MANIFESTATIONS (A LECTURE)
by: Tat’yana M Reshetnyak
Published: (2014-03-01) -
Clinical Phenotype of a First Unprovoked Acute Pulmonary Embolism Associated with Antiphospholipid Antibody Syndrome
by: Yong Sub Na, M.S., et al.
Published: (2019-01-01)